From Name:
From Email:
To Name:
To Email:

Optional Message:

New inroads against multiple sclerosis

from The JAMA Network

Medical progress against multiple sclerosis (MS) took a major leap forward in 2017 with the approval by the U.S. Food and Drug Administration (FDA) of ocrelizumab, a drug that has shown success against 2 different forms of the disease. The year also brought further signs that it may be possible to biochemically reverse damage wrought by MS. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063